"It shows a huge improvement in the cognitive ability of the patients, with the drug so far proving to be four-times more effective than the current treatment." Wonder if they are basing that off of old data (the interim Part A P300 being 4X better than donepezil last July) or new?
News 
Market Data 
Discover 
